Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of GnRH and raloxifene on uterine leiomyoma size
IRCT2014032816490N2Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Nov 2010
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of gonadorelin and raloxifene in Fibromyoma (LM) (2 arms), sponsored by Kurdistan University of Medical Sciences. Started Nov 2010; status: completed.
02
Drugs
gonadorelinraloxifene
03
Conditions
Fibromyoma (LM)
Beyond the preview
Go deeper on IRCT2014032816490N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014032816490N2.